Gain-of-function mutations in USP8 have been implicated in aberrant EGFR signaling in corticotrophs (73–75) and studies show USP8 mutations in 21-62% of corticotroph adenomas (76). The gene discussed is USP8; the disease is ACTH-producing pituitary gland adenoma.